Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dapagliflozin and Quality of Life Measured Using the EuroQol 5-Dimension Questionnaire in Patients with Heart Failure with Reduced and Mildly Reduced/Preserved Ejection Fraction

European Journal of Heart Failure(2024)10.1002/ejhf.3263Source: DataRank Database

Dapagliflozin and Quality of Life Measured Using the EuroQol 5-Dimension Questionnaire in Patients with Heart Failure with Reduced and Mildly Reduced/Preserved Ejection Fraction is a research paper published in European Journal of Heart Failure (2024). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 4.20)OA: hybridTopics (45)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Toru Kondo ORCID,Atefeh Talebi ORCID,Pardeep S. Jhund ORCID,Kieran F. Docherty ORCID,Brian Claggett ORCID

Live enrichment

PubMed:38700986 OpenAlex:https://openalex.org/W4396608343

British Heart Foundation Centre of Research Excellence

Grant: RE/18/6/34217

Vera Melrose Heart Failure Research Fund

FWCI

4.20

Citation Percentile

1.0%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ejhf.3263

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ejhf.3263

publisherhttps://academic.oup.com/eurjhf/article-pdf/26/7/1524/65512586/eurjhf_26_7_1524.pdf

journalhttps://doi.org/10.1002/ejhf.3263

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38700986

Fields of Study

Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsDiabetes Treatment and ManagementHumansQuality of LifeHeart FailureMaleStroke VolumeFemaleGlucosidesBenzhydryl CompoundsAgedSurveys and QuestionnairesMiddle AgedSodium-Glucose Transporter 2 Inhibitors

MeSH Terms

Sodium-Glucose Transporter 2 InhibitorsAgedBenzhydryl CompoundsFemaleGlucosidesHeart FailureHumansMaleMiddle AgedQuality of LifeSurveys and QuestionnairesStroke Volume

Keywords

MedicineEjection fractionHeart failureHazard ratioInternal medicineQuality of life (healthcare)Confidence intervalAtrial fibrillationDapagliflozinCardiologyVisual analogue scaleNatriuretic peptidePhysical therapyDiabetes mellitusEndocrinologyQuality of lifeSymptomsEq‐5d Index